Biblio

Export 222 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
M. Boada, Santos-Santos, M. A., Rodríguez-Gómez, O., Alegret, M., Cañabate, P., Lafuente, A., Abdelnour, C., Buendia, M., de Dios, M. José, Morera, A., Sanabria, Á., Campo, L., Ruiz, A., and Tárraga, L., “Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
M. Boada, Anaya, F., Ortiz, P., Olazarán, J., Shua-Haim, J. R., Obisesan, T. O., Hernandez, I., Muñoz, J., Buendia, M., Alegret, M., Lafuente, A., Tárraga, L., Núñez, L., Torres, M., Grifols, J. Ramon, Ferrer, I., Lopez, O. L., and Páez, A., “Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.”, J Alzheimers Dis, vol. 56, no. 1, pp. 129-143, 2017.
E. R. Blonz, “Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1223-1229, 2017.
V. Bloniecki, Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., and Freund-Levi, Y., “Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
I. Blockx, Einstein, S., Guns, P. - J., Van Audekerke, J., Guglielmetti, C., Zago, W., Roose, D., Verhoye, M., Van der Linden, A., and Bard, F., “Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.”, J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.
K. Bloch, Gil-Ad, I., Vanichkin, A., Hornfeld, S. Henry, Koroukhov, N., Taler, M., Vardi, P., and Weizman, A., “Intracerebroventricular Streptozotocin Induces Obesity and Dementia in Lewis Rats.”, J Alzheimers Dis, vol. 60, no. 1, pp. 121-136, 2017.
K. Bloch, Gil-Ad, I., Vanichkin, A., Hornfeld, S. Henry, Taler, M., Dar, S., Azarov, D., Vardi, P., and Weizman, A., “Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1445-1458, 2018.
K. Blennow and Zetterberg, H., “The Past and the Future of Alzheimer's Disease Fluid Biomarkers.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1125-1140, 2018.
J. Blautzik, Kotz, S., Brendel, M., Sauerbeck, J., Vettermann, F., Winter, Y., Bartenstein, P., Ishii, K., and Rominger, A., “Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 3, pp. 781-791, 2018.
C. M. Black, Fillit, H., Xie, L., Hu, X., M Kariburyo, F., Ambegaonkar, B. M., Baser, O., Yuce, H., and Khandker, R. K., “Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 185-193, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., “Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years.”, J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
M. Bjerke and Engelborghs, S., “Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1199-1209, 2018.
A. Bittar, Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., and Kayed, R., “Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
M. Bisbe, Fuente-Vidal, A., López, E., Moreno, M., Naya, M., de Benetti, C., Milà, R., Bruna, O., Boada, M., and Alegret, M., “Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial.”, J Alzheimers Dis, vol. 73, no. 2, pp. 769-783, 2020.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
B. K. Binukumar, Pelech, S. L., Sutter, C., Shukla, V., Amin, N. D., Grant, P., Bhaskar, M., Skuntz, S., Steiner, J., and Pant, H. C., “Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.”, J Alzheimers Dis, vol. 54, no. 2, pp. 525-33, 2016.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
J. Bin Bae, Han, J. Won, Kwak, K. Phil, Kim, B. Jo, Kim, S. Gyeom, Kim, J. Lan, Kim, T. Hui, Ryu, S. - H., Moon, S. Woo, Park, J. Hyuk, Youn, J. Chul, Lee, D. Young, Lee, D. Woo, Lee, S. Bum, Lee, J. Jae, Jhoo, J. Hyeong, and Kim, K. Woong, “Impact of Mild Cognitive Impairment on Mortality and Cause of Death in the Elderly.”, J Alzheimers Dis, vol. 64, no. 2, pp. 607-616, 2018.
M. Bilgel, Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., and Jedynak, B. M., “Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1335-1347, 2017.
N. Bier, Belchior, Pda Cunha, Paquette, G., Beauchemin, É., Lacasse-Champagne, A., Messier, C., Pellerin, M. - L., Petit, M., Mioshi, E., and Bottari, C., “The Instrumental Activity of Daily Living Profile in Aging: A Feasibility Study.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1361-71, 2016.
G. Biella, Fusco, F., Nardo, E., Bernocchi, O., Colombo, A., Lichtenthaler, S. F., Forloni, G., and Albani, D., “Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1193-207, 2016.
H. Bielarczyk, Jankowska-Kulawy, A., Hofling, C., Ronowska, A., Gul-Hinc, S., Rossner, S., Schliebs, R., Pawelczyk, T., and Szutowicz, A., “AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
R. V. Bhat, Andersson, U., Andersson, S., Knerr, L., Bauer, U., and Sundgren-Andersson, A. K., “The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?”, J Alzheimers Dis, vol. 64, no. s1, pp. S547-S554, 2018.
P. Bharadwaj, Wijesekara, N., Liyanapathirana, M., Newsholme, P., Ittner, L., Fraser, P., and Verdile, G., “The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.”, J Alzheimers Dis, vol. 59, no. 2, pp. 421-432, 2017.
M. A. Beydoun, Canas, J. - A., Dore, G. A., Beydoun, H. A., Rostant, O. S., Fanelli-Kuczmarski, M. T., Evans, M. K., and Zonderman, A. B., “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.

Pages